Dual-Agent Eye Drop for Presbyopia - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Dual-Agent Eye Drop for Presbyopia

YUVEZZI™ approved for the treatment of presbyopia, blurry close-up vision due to aging

  • April 20, 2026

  • 2 min

Share

Objective:

To introduce YUVEZZI™, a new dual-agent eye drop for the treatment of presbyopia in adults.

Approach:
    Key Findings:
    • YUVEZZI offers a single drop, once-daily dosing regimen.
    • Designed to enhance near vision and reduce reliance on reading glasses.
    • Available through e-pharmacy and retail pharmacies.
    Interpretation:

    YUVEZZI addresses the challenges of presbyopia with a convenient and effective treatment option, enhancing daily activities for affected individuals.

    Limitations:
    • Long-term efficacy and safety data are not yet fully established.
    • Accessibility may vary based on pharmacy partnerships.
    Conclusion:

    YUVEZZI represents a significant advancement in the management of presbyopia, providing a new therapeutic option for adults seeking improved near vision.

    Sources:

Original Source(s)

Dual-Agent Eye Drop for Presbyopia

  • April 20, 2026

Related Content

Presbyopia: Introducing Occupational Lenses

Why we should talk about occupational lenses with our presbyopic patients and the effective ways to educate them on their benefits.

Training Staff for the Presbyopia Journey

Presbyopia isn’t new—but the way we treat it has changed dramatically. As we continue to embrace these advancements, let’s also commit to the one constant that always makes a difference: a well-trained, well-informed team.

The Latest News in Ophthalmology

A look at the latest news in ophthalmology

  • September 1, 2025

  • 11 min